Abstract

BackgroundInfectious diseases, while associated with a much smaller proportion of deaths than they were 50 years ago, still play a significant role in mortality across the state of Massachusetts. Most analysis of infectious disease mortality in the state only take into account the underlying cause of death, rather than contributing causes of death, which may not capture the full extent of mortality trends for infectious diseases such as HIV and the Hepatitis C virus (HCV).MethodsIn this study we sought to evaluate current trends in infectious disease mortality across the state using a multiple cause of death methodology. We performed a mortality trend analysis, identified spatial clusters of disease using a 5-step geoprocessing approach and examined spatial-temporal clustering trends in infectious disease mortality in Massachusetts from 2002–2011, with a focus on HIV/AIDS and HCV.ResultsSignificant clusters of high infectious disease mortality in space and time throughout the state were detected through both spatial and space time cluster analysis. The most significant clusters occurred in Springfield, Worcester, South Boston, the Merrimack Valley, and New Bedford with other smaller clusters detected across the state. Multiple cause of death mortality rates were much higher than underlying cause mortality alone, and significant disparities existed across race and age groups.ConclusionsWe found that our multi-method analyses, which focused on contributing causes of death, were more robust than analyses that focused on underlying cause of death alone. Our results may be used to inform public health resource allocation for infectious disease prevention and treatment programs, provide novel insight into the current state of infectious disease mortality throughout the state, and benefited from approaches that may more accurately document mortality trends.

Highlights

  • In 1842, infectious diseases were the leading causes of death in Massachusetts, accounting for 47% of all deaths while in 2011 infectious diseases accounted for about 3% of all deaths in the state [1]

  • Most analysis of infectious disease mortality in the state only take into account the underlying cause of death, rather than contributing causes of death, which may not capture the full extent of mortality trends for infectious diseases such as Human immunodeficiency virus-1 (HIV) and the Hepatitis C virus (HCV)

  • While the HIV-1/AIDS epidemic hit its peak in the United States in the late 90s, and its incidence has been on the decline, its chronic nature and associated mortality rates still make it a major concern across the United States and Massachusetts [2]

Read more

Summary

Introduction

In 1842, infectious diseases were the leading causes of death in Massachusetts, accounting for 47% of all deaths while in 2011 infectious diseases accounted for about 3% of all deaths in the state [1]. Mortality trends for these diseases are not routinely examined in Massachusetts, and they typically rely solely on the underlying cause of death, and there may be long term and cyclical patterns that are not being detected. Most analysis of infectious disease mortality in the state only take into account the underlying cause of death, rather than contributing causes of death, which may not capture the full extent of mortality trends for infectious diseases such as HIV and the Hepatitis C virus (HCV). Methods: In this study we sought to evaluate current trends in infectious disease mortality across the state using a multiple cause of death methodology. We performed a mortality trend analysis, identified spatial clusters of disease using a 5step geoprocessing approach and examined spatial-temporal clustering trends in infectious disease mortality in Massachusetts from 2002–2011, with a focus on HIV/ AIDS and HCV. Our results may be used to inform public health resource allocation for infectious disease prevention and treatment programs, PLOS ONE | DOI:10.1371/journal.pone.0114822 December 11, 2014

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.